Preoperative risk stratification is essential in tailoring endometrial cancer treatment, and biomarkers predicting lymph node metastasis and aggressive disease are aspired in clinical practice. DNA ...
Objectives: We sought to determine the reliability of tumor typing and grading at the prehysterectomy curettage biopsy in patients with endometrial carcinoma. We also wanted to evaluate the overall ...
Several studies have identified L1 cell adhesion molecule (L1CAM) as a strong prognostic marker in endometrial cancer. To further underline the clinical usefulness of this biomarker, we investigated ...
Phase II trial of paclitaxel plus doxorubicin plus carboplatin in patients with intermediate risk, high risk, or recurrent endometrial carcinoma No significant financial relationships to disclose.
Screening tests check for a condition, like cancer, in people who don’t have any signs or symptoms. There aren’t any endometrial cancer screening tests for people at average risk. So, the best way to ...
D&C remains the most widely used technique for the initial workup of abnormal uterine bleeding. It is a relatively simple procedure, not requiring any expensive equipment (as is necessary with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results